Recombinant interferon gamma (Xiamen Amoytop Biotech/BioGeneric Pharma)
N/A
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant interferon gamma (Xiamen Amoytop Biotech/BioGeneric Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesXiamen Amoytop Biotech Co LtdBiogeneric Pharma
China Registration ClassN/A
Develop Information
Other Information
ATC Code
Related LinksN/A